To the Editor We read with great interest the systematic review and meta-analysis by Petrelli and colleagues published in JAMA Oncology. Among 1.5 million patients with colon cancer, those with left-sided tumors were shown to have better prognosis and lower risk of death in all stages compared with right-sided tumors. As the authors mention, different embryologic origin and poor histological and genetic features, including a higher rate of diploidy, mucinous histologic findings, microsatellite instability, CpG island methylation, and BRAF mutation in right-sided tumors, and more frequent p53 and KRAS mutations in left-sided tumors might explain the difference in prognosis, but the exact mechanism is not known.
http://ift.tt/2ovRE6V
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου